🇺🇸 FDA
Pipeline program

cleminorexton

ORX750-004

Phase 3 small_molecule active

Quick answer

cleminorexton for Narcolepsy Type 1 is a Phase 3 program (small_molecule) at Centessa Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Centessa Pharmaceuticals plc
Indication
Narcolepsy Type 1
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials